Johnson & Johnson (NY: JNJ )
152.65 UNCHANGED Streaming Delayed Price Updated: 7:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Headline News about Johnson & Johnson
Preview: Johnson & Johnson's Earnings
January 23, 2023
What 5 Analyst Ratings Have To Say About Johnson & Johnson
January 20, 2023
Tesla, Microsoft, IBM, Intel, TI Among Companies Reporting This Week: Can Netflix's Optimism Spill Over To Rest Of Tech Space?
January 22, 2023
Netflix, Inc. (NASDAQ: NFLX) shares jumped nearly 8.5% on Friday before settling at their highest level since April 19, 2022, when shares plunged after the company reported its first loss in net paid...
SVB Leerink raised the price target for BeiGene, Ltd. (NASDAQ: BGNE) from $236 to $300. SVB Leerink analyst Andrew Berens maintained an Outperform rating. BeiGene shares rose 2% to $279.90 in...
Johnson & Johnson's HIV Vaccine Regimen Does Not Prevent Infection, Phase 3 Study Shows
January 18, 2023
The Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) announced the results of an independent, scheduled data review of the Phase 3 Mosaico study of the investigational HIV vaccine...
Vistagen Poised To Begin Phase 1 Trial Of A Fast-Acting Antidepressant Nasal Spray In First Quarter Of 2023
January 17, 2023
In the race to create faster-acting, safer antidepressants, Vistagen (NASDAQ: VTGN) is starting the year strong as it gets ready to launch a Phase 1 Trial of its novel pherine nasal spray for Major...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following